The Ureteral Stents Market is entering a period of continued innovation as manufacturers focus on improving stent safety, patient comfort, durability, and ease of placement. Ureteral stents are essential in the treatment of urinary obstruction and are increasingly integrated into minimally invasive urological procedures.

The global market was valued at USD 668.0 million in 2025 and is projected to grow from USD 711.8 million in 2026 to USD 1,259.9 million by 2035. Market Research Future forecasts a CAGR of 6.55% over the 2026–2035 period.

One of the most important future trends is the development of biodegradable and bioabsorbable stents. Traditional stents often require removal following treatment, which can increase healthcare utilization and create additional inconvenience for patients. Biodegradable technologies are designed to provide temporary urinary drainage before gradually resorbing. According to Market Research Future, biodegradable stent designs are projected to grow at a CAGR of 10.75% through 2035.

Anti-encrustation technology is another major area of research. Encrustation can occur when mineral deposits accumulate on the surface of a stent, potentially causing complications during prolonged placement. Advanced coatings and improved material formulations are being explored to reduce these risks and improve long-term device performance.

Digital technologies could also influence the future of urological stent placement. Artificial intelligence and imaging technologies may assist clinicians in selecting appropriate stent dimensions and improving procedural planning. Digital follow-up systems could additionally help healthcare providers monitor patients and ensure timely stent management.

The shift toward ambulatory surgical centers is expected to continue. Market Research Future identifies ambulatory surgical centers as a rapidly developing end-user channel, while hospitals currently account for approximately 63.0% of end-user demand. This transition could increase demand for streamlined, single-use kits and easy-to-deploy stent systems.

Regionally, North America is expected to retain its leadership position, while Asia-Pacific offers considerable growth potential. The region's projected 8.15% CAGR reflects improving healthcare infrastructure and increasing access to specialized urological procedures.

Kidney stone management will remain a fundamental application, representing approximately 56.8% of the market in 2025. However, growing demand for tumor-related obstruction management and transplant-related procedures should broaden the application landscape.

Overall, the future of the Ureteral Stents Market will be shaped by biodegradable materials, anti-encrustation solutions, minimally invasive procedures, digital technologies, and expansion into emerging healthcare markets.